Ribociclib: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of ce... |
No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | ||
Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. | Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. ribociclib, abemaciclib inhibits the enzymes [[Cyclin Dependent Kinase-4|cyclin-dependent kinase 4]] (CDK4) and cyclin-dependent kinase 6 (CDK6). | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
